Financial Review: NeurAxis (NASDAQ:NRXS) vs. Viveve Medical (NASDAQ:VIVE)

Viveve Medical (NASDAQ:VIVE) and NeurAxis (NASDAQ:NRXS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Analyst Ratings

This is a breakdown of current ratings for Viveve Medical and NeurAxis, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Viveve Medical	0	0	0	0	N/A
NeurAxis	0	0	0	0	N/A

Profitability

This table compares Viveve Medical and NeurAxis’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Viveve Medical	N/A	N/A	N/A
NeurAxis	-672.66%	N/A	-787.15%

Risk and Volatility

Viveve Medical has a beta of 0.54, meaning that its share price is 46% less volatile than the S&P 500. Comparatively, NeurAxis has a beta of 4.3, meaning that its share price is 330% more volatile than the S&P 500.

Valuation & Earnings

This table compares Viveve Medical and NeurAxis”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Viveve Medical	$6.83 million	0.00	-$22.03 million	N/A	N/A
NeurAxis	$2.27 million	8.00	-$14.63 million	($2.94)	-0.90

NeurAxis has lower revenue, but higher earnings than Viveve Medical.

Insider & Institutional Ownership

11.8% of NeurAxis shares are owned by institutional investors. 5.7% of Viveve Medical shares are owned by insiders. Comparatively, 15.2% of NeurAxis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

NeurAxis beats Viveve Medical on 5 of the 8 factors compared between the two stocks.

About Viveve Medical

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

About NeurAxis

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.